Pharma major AstraZeneca has said it is working to expedite the review of the single event to minimise any potential impact on the trial timeline of its Covid-19 vaccine candidate.
AstraZeneca said in a statement that as part of the ongoing randomised, controlled clinical trials of the AstraZeneca Oxford coronavirus vaccine, AZD1222, a standard review process has been triggered.
The review process has led to the voluntary pause of vaccination across all trials to allow an independent committee to review the safety data of a single event of an unexplained illness that occurred in the UK Phase III trial, the company said.
<blockquote class="twitter-tweet">
Pharma major <a href="https://twitter.com/AstraZeneca?ref_src=twsrc%5Etfw">@AstraZeneca</a> said it is working to expedite the review of the single event to minimise any potential impact on the trial timeline of its <a href="https://twitter.com/hashtag/Covid19vaccine?src=hash&amp;ref_src=twsrc%5Etfw">#Covid19vaccine</a> candidate.<a href="https://twitter.com/hashtag/COVID19?src=hash&amp;ref_src=twsrc%5Etfw">#COVID19</a> <a href="https://t.co/sjJR3CUjn7">pic.twitter.com/sjJR3CUjn7</a>
&mdash; IANS Tweets (@ians_india) <a href="https://twitter.com/ians_india/status/1303967718081613826?ref_src=twsrc%5Etfw">September 10, 2020</a></blockquote>
<script charset="utf-8" type="text/javascript" src="https://platform.twitter.com/widgets.js"></script>
"This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials", it said.
"In large clinical trials, illnesses will happen by chance and must be independently reviewed. AstraZeneca is working to expedite the review of the single event to minimise any potential impact on the trial timeline. We are committed to the safety of our participants and the highest standards of conduct in our trials", the company said.
Pascal Soriot, Chief Executive Officer, said: "At AstraZeneca we put science, safety and the interests of society at the heart of our work. This temporary pause is living proof that we follow those principles while a single event at one of our trial sites is assessed by a committee of independent experts. We will be guided by this committee as to when the trials could restart, so that we can continue our work at the earliest opportunity to provide this vaccine broadly, equitably and at no profit during this pandemic."
<h3>Keep scrolling to read more news</h3>
Catch up on all the latest <a title="mid-day news" href="https://www.mid-day.com/news" target="_blank">Crime, National, International and Hatke news</a> here. Also download the new mid-day <a title="mid-day android app " href="https://goo.gl/8Xlcvr" target="_blank">Android</a> and <a title="mid-day iOS app" href="https://goo.gl/KQziH4" target="_blank">iOS</a> apps to get latest updates. 
Mid-Day is now on Telegram. Click here to join our channel (<a title="MID-DAY on Telegram" href="https://t.me/middayinfomedialtd" target="_blank">@middayinfomedialtd</a>) and stay updated with the latest news
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

AstraZeneca said in a statement that as part of the ongoing randomised, controlled clinical trials of the AstraZeneca Oxford coronavirus vaccine, AZD1222, a standard review process has been triggered 

Panel to decide on AstraZeneca Covid vax trials after unsolved illness

Trending Stories

Latest Photos

Latest Videos

Latest Web Stories

Ganeshotsav 2026

Home / News / India News / Article / Panel to decide on AstraZeneca Covid vax trials after unsolved illness

Panel to decide on AstraZeneca Covid vax trials after unsolved illness

Trending Stories

Latest Photos

Latest Videos

Latest Web Stories

Ganeshotsav 2026